meropenem 1g powder for solution for injection vials
pfizer ltd - meropenem trihydrate - powder for solution for injection - 1gram
meropenem aurobindo 500mg powder for solution for injection or infusion
aurobindo pharma (malta) limited - meropenem - powder for solution for injection/infusion - 500 milligram(s) - carbapenems; meropenem
meropenem 500mg powder for solution for injection vials
milpharm ltd - meropenem trihydrate - powder for solution for injection - 500mg
meropenem 1g powder for solution for injection vials
bowmed ibisqus ltd - meropenem trihydrate - powder for solution for injection - 1gram
meropenem kabi. powder for solution for injection/infusion
fresenius kabi deutschland gmbh, germany - meropenem - powder for solution for injection/infusion - 500 mg
meropenem for injection powder for solution
jamp pharma corporation - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg
meropenem anfarm 500 mg
k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 500 mg/vial - meropenem - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency
meropenem anfarm 1 g
k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency
taro-meropenem powder for solution
sun pharma canada inc - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems
dbl™ meropenem for injection
pfizer new zealand limited - meropenem trihydrate 570.475mg equivalent to meropenem 500 mg - powder for injection - 500 mg - active: meropenem trihydrate 570.475mg equivalent to meropenem 500 mg excipient: nitrogen sodium carbonate - dbl meropenem for injection is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: · community acquired lower respiratory tract infection · hospital acquired lower respiratory tract infection · complicated urinary tract infection · febrile neutropenia · intra-abdominal and gynaecological (polymicrobial) infections · complicated skin and skin structure infections · meningitis · septicaemia